China Resources Jiangzhong Pharmaceutical Co., Ltd. (600750.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 22.49

From 52W high−18.67%

Volume3.08M

Market capCNY 14.31B

P/E (TTM)15.8x

P/S (TTM)3.5x

Div yield8.45%

Key dataSep 18, 2026

Open

CNY 22.49

From 52W high

−18.67%

Volume

3.08M

Market cap

CNY 14.31B

ValuationView details →

P/E (Fwd)

15.0x

EV/EBITDA

10.4x

P/E (TTM)

15.8x

RSI (14)

35.7

MomentumView details →

1D Return

−8.53%

YTD Return

−4.01%

ValuationView details →

P/E (Fwd)

15.0x

P/E (TTM)

15.8x

EV/EBITDA

10.4x

EV/Sales

3.4x

P/S (TTM)

3.5x

P/B (TTM)

3.6x

ProfitabilityView details →

Gross Margin

65.24%

Net Margin

22.35%

EBITDA Margin

33.15%

ROE (TTM)

21.08%

ROA (TTM)

12.71%

Asset Turnover

0.58x

GrowthView details →

Revenue YoY

−6.31%

EPS YoY

+12.69%

FCF YoY

−10.07%

Revenue CAGR 3Y

+2.79%

EPS CAGR 3Y

+14.61%

EBITDA YoY

—

MomentumView details →

1D Return

−8.53%

YTD Return

−4.01%

1Y Return

+2.96%

RSI (14)

35.7

vs 50D SMA

−8.30%

vs 200D SMA

−8.91%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

1.86x

Quick Ratio

1.64x

Div Yield

8.45%

Div Rate

CNY 1.88

Div Growth 1Y

+15.00%

EarningsView details →

EPS (Actual)

CNY 0.32

EPS Surprise

−16.12%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.28

Avg Surprise (4Q)

−16.12%

Rev Surprise

−2.40%

Financials snapshotView financials →

Revenue (TTM)

4.07B

Net Income (TTM)

909.82M

Op. CF (TTM)

826.05M

Next earningsOct 26, 2026 →

Latest newsMore news →

China Resources Jiangzhong received a traditional Chinese medicine registration certificate (No. MAC-C00615) from Macao's Pharmaceutical Administration Bureau for its Jianwei Xiaoshi tablets, allowing sales in Macao.10d ago

China Resources Jiangzhong announced its first-half 2026 results: net profit attributable to shareholders was 491 million yuan, down 5.92% year-on-year.30d ago

Similar companies

海正药业600267.SH 九洲药业603456.SH Neurocrine Biosciences, Inc.NBIX Fujian Haixi Pharmaceuticals Co., Ltd.02637.HK 步长制药603858.SH 健友股份603707.SH Find similar companies →

Latest newsMore news →

China Resources Jiangzhong received a traditional Chinese medicine registration certificate (No. MAC-C00615) from Macao's Pharmaceutical Administration Bureau for its Jianwei Xiaoshi tablets, allowing sales in Macao.10d ago China Resources Jiangzhong announced its first-half 2026 results: net profit attributable to shareholders was 491 million yuan, down 5.92% year-on-year.30d ago